Caxton Associates (New York)’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-11,842
Closed -$1.04M – 628
2022
Q1
$1.04M Buy
11,842
+5,941
+101% +$612K 0.08% 100
2021
Q4
$611K Buy
+5,901
New +$630K 0.06% 225
2021
Q2
– Sell
-12,535
Closed -$834K – 525
2021
Q1
$834K Buy
12,535
+8,638
+222% +$583K 0.08% 88
2020
Q4
$262K Buy
+3,897
New +$253K 0.02% 92
2019
Q4
– Sell
-9,844
Closed -$444K – 456
2019
Q3
$444K Buy
+9,844
New +$436K 0.09% 152
2017
Q4
– Sell
-13,827
Closed -$541K – 415
2017
Q3
$541K Buy
+13,827
New +$505K 0.02% 310

Other funds holding HLI

Caxton Associates (New York)'s HLI Position: Q2 2022 in Review

Caxton Associates (New York) sold out of Houlihan Lokey (HLI) in Q2 2022, closing a stake of 11,842 shares — an estimated $1.04M sold.

Caxton Associates (New York) first reported a position in HLI in Q3 2017 and held it in 6 quarters. The position peaked at $1.04M in Q1 2022. 323 funds tracked by Wall St. Rank hold HLI as of Q2 2022.

  • Caxton Associates (New York) reported no remaining Houlihan Lokey position as of Q2 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 11,842 Houlihan Lokey shares in Q2 2022, an estimated $1.04M.
  • Caxton Associates (New York) first reported a position in Houlihan Lokey in Q3 2017 and held it in 6 quarters.
  • Caxton Associates (New York)'s Houlihan Lokey position peaked at $1.04M in Q1 2022.
  • 323 funds tracked by Wall St. Rank held Houlihan Lokey as of Q2 2022.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.